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A B S T R A C T
Oats contain a range of phenolic acids and avenanthramides which may have health benefits. Analysis of 22
commercial oat products (oat bran concentrate, oat bran, flaked oats, rolled oats and oatcakes) using HPLC-DAD
detected eleven bound and thirteen free+ conjugated phenolic acids and avenanthramides. The oat products
(excluding concentrate) provided between 15.79 and 25.05mg total phenolic acids (9.9–19.33mg bound,
4.96–5.72mg free+ conjugated) and between 1.1 and 2mg of avenanthramides in a 40 g portion while an 11 g
portion of oat concentrate provided 16.7mg of total phenolic acids (15.17mg bound, 1.53mg free+ con-
jugated) and 1.2mg of avenanthramides. The compositions and concentrations of the components in the dif-
ferent products were broadly similar, with the major component being ferulic acid (58–78.1%). The results show
that commercial oat products are a source of phenolic acids and avenanthramides for consumers.
1. Introduction
Epidemiological evidence suggests that regular consumption of
whole grains is associated with a lower risk of chronic diseases, such as
cardiovascular disease (CVD), type 2 diabetes and certain cancers
(Reynolds et al., 2019). Meta-analyses of multiple human intervention
studies provide strong evidence that regular oat intake lowers blood
cholesterol, improves insulin sensitivity and post-prandial glycaemic
control (Bao, Cai, & Xu, 2014; Ho et al., 2016). Oats (Avena sativa) are
wholegrain cereals which provide proteins, unsaturated fatty acids,
vitamins, minerals (Singh, De, & Belkheir, 2013), phenolics (including
avenanthramides that are unique to oats), and significant quantities of
dietary fibre, including cellulose, arabinoxylan and β-glucan. (Menon
et al., 2016). There is a solid body of evidence and a health claim by
EFSA approving the cholesterol lowering properties of oat β-glucans.
(Efsa Panel on Dietetic Products & Allergies, 2011; Ho et al., 2016). A
diet rich in oats can provide phenolic acids and avenanthramides that
may contribute to the beneficial health effects. Although there are
mixed findings from different studies testing different foods, well
designed randomized controlled trials investigating a variety of foods
such as coffee and blueberries showed protective effects of circulating
phenolics against CVD (Mills et al., 2017; Rodriguez-Mateos et al.,
2016; Rodriguez-Mateos et al., 2013; Sawicki et al., 2016; Schar et al.,
2015). Avenanthramides have also been shown to be bioavailable in
humans and may exert anti-inflammatory, anti-proliferative and vaso-
dilatory effects to protect against CVD and colon cancer (Bryngelsson,
Dinberg, & Kamal-Eldin, 2002; Chen, Milbury, Collins, & Blumberg,
2007; Liu, Zubik, Collins, Marko, & Meydani, 2004; Nie, Wise, Peterson,
& Meydani, 2006; Xie et al., 2017).
Phenolic acids comprise one aromatic ring bearing an acid group
and one or more hydroxyl groups (Li, Shewry, & Ward, 2008) and are
present in the oat grain in three forms: as soluble free acids, as soluble
conjugates esterified to low molecular weight components such as su-
gars, and as insoluble bound acids esterified to high molecular weight
components, notably cell wall polysaccharides (dietary fibre and lignin)
(Collins, 1986). Cereal phenolic acids consist of two major types: based
on either hydroxycinnamic acid or hydroxybenzoic acid. Hydro-
xybenzoic acids in oats include protocatechuic, syringic, vanillic, p-
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hydroxybenzoic and gallic acids, while hydroxycinnamic acids in oats
are ferulic, p-coumaric, o-coumaric, caffeic and sinapic acids
(Supplementary Fig. 1) (Shewry et al., 2008). Avenanthramides consist
of an amide conjugate of anthralinic acid and hydroxycinnamic acids.
The 3 major types are esters of 5-hydroxyanthranilic acid with p-cou-
maric (2p aka A), and ferulic (2f aka B), and caffeic (2c aka C) acids
which occur predominantly in the bran layer of the oat grain
(Supplementary Fig. 1) (Bratt et al., 2003; Collins, 1989).
Several previous studies have reported the presence and amounts of
phenolic acids and avenanthramides in oats (Dimberg, Gissen, &
Nilsson, 2005; Mattila, Pihlava, & Hellstrom, 2005; Shewry et al.,
2008). However, some of these studies analysed experimental material
(including hulled grains) which would not be available to consumers
while others analysed either avenanthramides or phenolic acids but not
the two groups together. Therefore, the aim of this study was to de-
termine the composition and amounts of phenolic acids and avenan-
thramides in a number of commercial oat samples, determining dif-
ferences between products (oat bran, oat bran concentrate, rolled,
flaked oats and oat cakes) and estimating the amounts consumed in
typical portions of oat-based products in order to understand their
contribution to dietary intakes of phenolics and to inform further
clinical trials aiming to test the bioactivity of these compounds at
normal intake levels.
2. Materials & methods
2.1. Chemicals and reagents
All individual phenolic acid and avenanthramide standards were
obtained from Sigma-Aldrich (St. Louis, MO, USA). HPLC column and
guard cartridges were obtained from Phenomenex (Torrance, CA, USA).
Unless otherwise stated, all chemicals and reagents were obtained from
Sigma-Aldrich or Fisher Scientific.
2.2. Oat samples
22 commercial oat products were purchased in local shops or online
and comprised 5 oat brans, 5 oat flakes, 6 rolled oats, 5 oatcakes and
one oat concentrate (Table 1). The samples were milled using a coffee
grinder and kept at −20 °C until analysis to protect bioactive
ingredients from degradation.
2.3. Extraction of free, conjugated and bound phenolic acids
Phenolic acids and avenanthramides were extracted in two separate
fractions (i.e. free+ conjugated and bound) (Supplementary Fig. 2), in
three replicates, using the method of Schär et al. (2018). 2 mL of hexane
were added to 20.0 ± 0.1mg of milled oat samples for defatting. So-
lutions were vortexed for 30 s, sonicated for 10min, vortexed and kept
on a shaker for 50min. Following centrifugation for 15min at 5000 rcf,
the supernatant was discarded and the wet samples were dried with a
Savant™ SPD131DDA SpeedVac™ Concentrator (ThermoFisher Scien-
tific, Waltham, MA, USA) for 10min. The first extraction step was
carried out by adding 80:20 ethanol/water (1mL) and samples were
vortexed until all of the flour was suspended. 0.375µg of internal
standard (3-5,dichloro-4-hydroxybenzoic acid) was added and the
samples were extracted for 10min by sonication in a sonic bath. Sam-
ples were then heated to 80 °C for 15min and centrifuged for 15min at
5000g. The supernatant was removed into a test tube and evaporated
with a SpeedVac. This extraction was repeated twice without the
heating and the addition of internal standard. The combined super-
natants were evaporated to dryness. For the extraction of free+ con-
jugated fractions, the dried supernatant was hydrolysed with 2M NaOH
(400 μl) with 10 μM EDTA and 1% (w/v) ascorbic acid for 4 h and then
acidified with 12M HCl (125 μl) to pH 2 and kept at −20 °C overnight.
For the extraction of the bound fraction, the pellet was dried in a
Speedvac for 5min, 30 μg internal standard added and hydrolysis was
carried out with 2M NaOH solution (800 μl), 10 μM EDTA and 1% (w/
v) ascorbic acid for 16–18 h with gentle agitation. Following hydrolysis,
samples were centrifuged for 15min at 16,100g, supernatants were
transferred to clean Eppendorf tubes and acidified with 12M HCl
(220 μl). Bound and free+ conjugated fractions were extracted with
ethyl acetate (3× 800 μl), evaporated to dryness and re-dissolved in
2% (v/v) aqueous acetic acid (100 μl) using vortexing for 30 s, soni-
cation for 1min and shaking for an hour. Final solutions were cen-
trifuged for 5min at 16,100g and transferred to vials containing a low
volume insert for HPLC analysis.
2.4. HPLC analysis
Phenolic acids and avenanthramides were identified and quantified
using an Agilent 1100 series HPLC (Agilent Technologies Ltd, Santa
Clara, CA, USA) equipped with a quaternary pump, autosampler,
column thermostat, sample thermostat and photodiode array detector.
Phenolic acids were separated on a Kinetex biphenyl column (100A
250×4.6mm length, 5 μM particle size; Phenomenex) using a gradient
elution programme developed in house for the separation of 18 dif-
ferent phenolic acids and 3 avenanthramides. Mobile phase A consisted
of 0.1% (v:v) formic acid in HPLC grade water (A), while mobile phase
B was 0.1% (v:v) formic acid in methanol. The following optimised
gradient protocol was run: 0min, 95% A; 20min, 75% A; 25min, 74%
A; 30min, 65% A; 40min, 64% A; 53min, 30% A; 56min, 5% A;
61min, 5% A; 62min, 95% A; 65min, 95% A. The flow rate of the
mobile phase was 1.0mL/min, the column temperature was 30 °C and
the sample injection volume was 20 µl. Quantification of phenolic acids
and avenanthramides were made at 280 nm. The retention time and
absorbance of each compound was established by running standards
(Supplementary Table 1). All standards were prepared as stock solu-
tions at 1mg/mL in methanol and stored at −80 °C. Phenolic acids and
avenanthramides were quantified by calculating the ratio of the area of
the analyte to the area of the internal standard (i.e. 3-5,dichloro-4-
hydroxybenzoic acid). Quantification was based on 10 point linear
calibration curves of phenolic acid and avenanthramide standards
which covered the range present in the oat samples and had R2 values
above 0.9 (Supplementary Table 1). The concentrations of individual
components were stated as μg/g. Good reproducibility was observed
Table 1
Brands, names, types and numbers of commercial oat products.
Brand Type Number
Oatwell Bran concentrate 1
White’s (Fine cut) Bran 2
Mornflake Bran 3
Sante (Otreby Owsiane) Bran 4
Greenlands (organic) Bran 5
M&S (Traditional British porridge oats) Flaked 6
Sainsbury’s (SO organic Scottish oats) Flaked 7
Sainsbury’s (Scottish porridge oats) Flaked 8
Flahavan’s (Irish organic jumbo oats) Flaked 9
Kupiec (plain) Flaked 10
Quaker (Oats so simple original-sachets) Rolled 11
Sainsbury’s (Taste the difference Scottish) Rolled 12
Asda (Original porridge) Rolled 13
Quaker (Jumbo oats) Rolled 14
Quaker Rolled 15
Scott’s (Porridge oats) Rolled 16
Nairns (Fine milled, 85% oats) Oatcake 17
Nairns (Organic, enriched with oatbran, 85% oats) Oatcake 18
Savour Bakes (Scottish rough, 89% oats) Oatcake 19
Clearspring (Organic, 83% oats) Oatcake 20
Paterson’s (Rough, % *ng) Oatcake 21
Stockan’s (Orkney, thin, 76% oats) Oatcake 22
* ng (not given); proportion of oat (%) is not provided on the package of the
product.
G. Soycan, et al. Food Chemistry: X 3 (2019) 100047
2
between replicate analyses with an average of 9% for the coefficient of
variation for all samples. All data were analysed using Agilent Chem
Station software.
2.5. Statistical analysis
Means and standard errors of 3 replicates were calculated for each
sample. Data were quantified and expressed as μg/g fresh weight.
Calibration curves of phenolic acid and avenanthramide standards were
created by MS Excel 2010.
3. Results and discussion
3.1. Identification of phenolic acids and avenanthramides in commercial
oat products
Standards of twenty different phenolic compounds (including phe-
nolic acids and avenanthramides) which could be present in oat pro-
ducts were analysed by HPLC-DAD (Fig. 1A), measuring their absor-
bance maxima and retention times (Supplementary Table 1).
Comparisons with these standards identified eleven components in the
bound fractions and thirteen in the free+ conjugated fractions
Fig. 1. Chromatogram of phenolic acid and avenan-
thramide standards at 280 nm (A) and representative
chromatograms of bound phenolic acids (B) and
free+ conjugated phenolic acids oat from sample 3
(Table 1) for at 280 nm (C). Compounds were iden-
tified based on retention time and absorbance spectra
(Supplementary Table 1): 1, gallic acid; 2, 4-hydro-
xybenzoic acid; 3, 2,4-dihydroxybenzoic acid; 4, 4-
hydroxyphenyl acetic acid; 5, caffeic acid; 6, vanillic
acid; 7; 4-hydroxybenzaldehyde; 8, homovanillic
acid; 9, syringic acid; 10, p-coumaric acid; 11, va-
nillin; 12, salicylic acid; 13, ferulic acid; 14, syr-
ingaldehyde; 15, sinapic acid; 16, 3-5, dichloro-4-
hydroxybenzoic acid; 17, o-coumaric acid; 18, ave-
nanthramide C; 19, avenanthramide A; 20, avenan-
thramide B.
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extracted from the products. This is illustrated by the typical chroma-
tograms for oat bran (product 3) in Fig. 1B and C. While both the bound
and free+ conjugated fractions contained 4-hydroxybenzoic acid, va-
nillic acid, caffeic acid, 4-hydroxybenzaldehyde, syringic acid, p-cou-
maric acid vanillin, ferulic acid and sinapic acid, the three avenan-
thramides (avenanthramide A, avenanthramide B and avenanthramide
C) were only present in the free+ conjugated fractions.
3.2. Total contents of phenolic acids and avenanthramides
The mean total contents of phenolic acids and avenanthramides in
the groups of oat products was highest for the oat bran concentrate
(1518.6 μg/g) followed by oat bran (626.3 ± 60.1 μg/g), flaked oats
(438.1 ± 27.0 μg/g), rolled oats (415.8 ± 14.9 μg/g) and oatcakes
(394.8 ± 24.2 μg/g) (Fig. 2A). All the results are reported on a fresh
weight (FW) basis. The bound phenolic acid fraction made the greatest
contribution to the total phenolic contents of all products (62.7–90.8%)
while the amounts of the free+ conjugated fractions were lower in all
products (9.2–37.2%). This is in agreement with other studies (Multari
et al., 2018; Zeng, Liu, Luo, Chen, & Gong, 2016). When the contents
and compositions of phenolic acids and avenanthramides were com-
pared within each group of oat products, the bran products showed the
greatest variation in both free+ conjugated (ranging from 100.9 to
194.9 μg/g) and bound (ranging from 359.5 to 592.4 μg/g) fractions,
the free+ conjugated fraction also varied between the samples of oat
flakes (115.7–210 μg/g). Oat bran concentrate comprises mainly fibre
and, in agreement with the literature, our analysis showed that this
fraction was rich in bound phenolic acids (Peterson, 2001). The total
contents of phenolic acids in the oat bran products were only slightly
higher than those in the flaked oats, rolled oats and oatcake products.
Similar results for different oat products were reported by Mattila et al.
(2005) who suggested that the similar phenolic content of oat bran and
other oat products might be due to the processing method which results
in the bran containing some aleurone and starchy endosperm as well as
outer layers of the grain (pericarp and testa) (Chen, Wang, Wang, &
Luo, 2018; Mattila et al., 2005).
Avenanthramides were only present as soluble forms with the mean
total concentrations being highest in oat bran (49.6 ± 8.3 μg/g) fol-
lowed by flaked oats (48.8 ± 10.3 μg/g), oatcakes (43.8 ± 6.9 μg/g),
oat bran concentrate (30.6 μg/g) and rolled oats (28.3 ± 2.9 μg/g)
(Fig. 2C). Avenanthramides have been reported to be heat stable under
conditions of commercial processing and the levels of these compounds
in oatcakes, which are mostly processed products in our sample range,
were higher than in the oat bran concentrate which contained highest
total levels of phenolic acids (Dinberg, Sunnerheim, Sundberg, & Walsh,
2001). The concentrations determined in this study were broadly con-
sistent with those reported previously (Chen et al., 2018; Mattila et al.,
2005; Pridal, Bottger, & Ross, 2018; Shewry et al., 2008). However,
whereas Chen et al. (2018) and Pridal et al. (2018) reported higher
concentrations of avenanthramides in oat bran samples in comparison
to whole oats, including rolled oats, Mattila et al. (2005) reported that
commercial oat bran products produced by conventional milling tech-
niques could not be discriminated from oat flakes based on their ave-
nanthramide content, which is in agreement with our results. It should
also be noted that the contents of phenolic acids and avenanthramides
in oat grain will vary with the crop genotype and the growth conditions
(including location and environment) (Li et al., 2017; Pridal et al.,
2018).
3.3. Compositions and individual contents of phenolic acids and
avenanthramides
The most abundant bound phenolic acids in all oat products ana-
lysed were ferulic acid, caffeic acid and sinapic acid (Table 2). The oat
bran concentrate had the highest concentrations of these compounds in
the bound fraction (1153.6 μg/g, 72.2 μg/g and 80.3 μg/g, respectively)
whereas oatcakes had the lowest (191.1 ± 14.2 μg/g, 11.9 ± 0.9 μg/g
and 21.7 ± 1.1 μg/g, respectively). Ferulic acid, sinapic acid and
avenanthramide B were the major components in the free+ conjugated
fractions of all products, with rolled oats having the highest con-
centration of ferulic acid (40.8 ± 2.2 μg/g), oat bran concentrate the
highest concentration of sinapic acid (36.2 μg/g) and oat bran the
highest concentration of avenanthramide B (27.6 ± 4.6 μg/g).
The compositions of oat phenolics reported in other studies are
largely in line with our findings, but there are few inconsistencies.
Ferulic acid was reported to be the major component in both fractions
by other workers (Mattila et al., 2005b; Multari et al., 2018; Shewry
et al., 2008). However, p-coumaric acid has also been reported to be
highly abundant in other studies whereas the concentrations in our
study were low (Bryngelsson et al., 2002; Kováčová & Malinová, 2007;
Shewry et al., 2008). In agreement with Chen et al. (2018), avenan-
thramide-B was the predominant avenanthramide. However, the con-
centrations of avenanthramide-C reported here are lower than in other
studies (Multari et al., 2018; Shewry et al., 2008). These inconsistencies
may be due to differences in samples used (e.g. the samples analysed by
Shewry et al. (2008) contained the hulls which are rich in p-coumaric
acid), the methods used for extraction and analysis, and genetic and
environmental factors.
3.4. Multivariate analysis of phenolic acid and avenanthramide
composition
Principal component analyses (PCA) of the phenolics present in the
bound and free+ conjugated fractions are shown in Figs. 3 and 4, re-
spectively. Panels A, C and E are PCA score plots which show the
grouping of oat products based on their overall phenolic acid compo-
sitions while panels B, D and F are the corresponding loading plots
which show the individual phenolic acids responsible for the separa-
tion. For the bound fraction, all three score plots showed clear clus-
tering of the rolled oats, oatcake and flaked oats in the centre of the
plot, and separation of the single oat concentrate. Comparison of the
score and loadings plots indicates that the latter separation mainly re-
sults from the very high content of ferulic acid (see also Table 2). The
four bran samples do not cluster, but pairs of samples group together in
all three plots and these pairs can be distinguished by their high and
low contents of p-coumaric acid.
By contrast, the free+ conjugated fraction does not show any clear
clustering (Fig. 4). Because bound phenolic acids represent about 80%
of the total, PCA analysis of the total fraction was essentially similar to
that of the bound fraction (not shown).
The greater variation in the contents of free+ conjugated compo-
nents compared to bound, both within and between the types of sample,
may reflect wider variation in the composition of the raw material. For
example, studies of wheat have shown that the growing conditions have
a much greater impact on the content and composition of free and
conjugated phenolic acids than on bound phenolic acids, with herit-
abilities calculated as 6.4%, 9.8% and 28.5%, respectively (Shewry
et al., 2010). The solubility of these components could also lead to
greater losses during processing.
3.5. Potential health benefits of phenolic acids and ferulic acid and intake
from commercial oat products
It has been suggested that the consumption of dietary phenolics may
reduce the risk of chronic diseases such as CVD, diabetes, cancer and
neurodegenerative diseases (Shahidi & Yeo, 2018). The average daily
intake of phenolic acids in Europe is 605mg/day, with wholegrains
contributing about 5.5% of the total, while the ferulic acid intake is
38mg/day (Zamora-Ros et al., 2016). Previous studies carried out in
humans reported significant improvements in vascular function fol-
lowing a single dose of phenolics in 375mL of champagne (61.63mg/l)
and chlorogenic acids (89 and 310mg/g) in 3.6 g of coffee (Mills et al.,
G. Soycan, et al. Food Chemistry: X 3 (2019) 100047
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Fig. 2. The amounts of total, conjugated+ free and bound phenolic acids (A), ferulic acid (B) and total avenanthramides (C) in oat products including oat bran, oat
bran concentrate, flaked oats, rolled oats and oatcake. Data are expressed as the mean ± SEM. n indicates the number of each product analysed. FW, fresh weight.
G. Soycan, et al. Food Chemistry: X 3 (2019) 100047
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2017; Vazour et al., 2010). Our study showed that the consumption of a
40 g portion of commercial oat products provides from 15.8 to 25.1mg
total phenolics (from 9.9 to 19.3mg bound and from 4.9 to 5.7mg
free+ conjugated phenolics) including 1.1–2mg avenanthramides and
16.7mg of total phenolics (15.2mg of bound and 1.5 mg of
free+ conjugated phenolics) including 1.2 mg of avenanthramides in a
11 g portion of oat bran concentrate.
Ferulic acid is the major component present in all commercial oat
products and our analyses show that between 9.1 and 14.7mg of total
ferulic acid (from 7.6 to 13.3mg bound and from 1.4 and 1.6mg
free+ conjugated fraction) can be provided in a 40 g portion of com-
mercial oat products and 13.1mg of total ferulic acid (12.7 mg of bound
and 1.3 mg free+ conjugated fraction) can be provided in a 11 g por-
tion of oat bran concentrate. A number of studies have reported ther-
apeutic effects of ferulic acid against diseases related to oxidative stress,
with an increasing body of evidence for a role in the prevention or
management of chronic disease (Kumar & Pruthi, 2014). For example,
randomized controlled trials to determine the effect of coffee and
cranberries on vascular health showed improvements on outcomes such
as flow mediated dilatation (FMD) and these findings were correlated
with the presence of ferulic acid metabolites (Mills et al., 2017;
Rodriguez-Mateos et al., 2016). We would therefore predict that the
consumption of oat phenolics, and ferulic acid in particular, may have
similar health benefits.
In conclusion, this study showed that wholegrain oat products can
provide a source of phenolic compounds. The total concentrations of
phenolic acids and avenanthramides ranged from 394.8 ± 24.2 to
1518.6 μg/g, with oat bran concentrate having the highest content and
the other wholegrain products and oat bran containing lower but si-
milar amounts. However, the total contents of free+ conjugated phe-
nolic acids and avenanthramides were similar in all products. This is
important as this fraction should be more bioaccessible and absorbed in
the small intestine, whereas the bound fraction will only be released, at
least partially, during fermentation in the colon. Consequently, similar
potential health benefits could be delivered by all products analysed.
These data could be useful to inform studies of human dietary intake
and interventions with oat products to better understand the health
benefits of oats.
Fig. 3. Principal component analysis of the contents of bound phenolic acids in different oat products. A, C and E are score plots and B, D and F the corresponding
loading plots. Letters on loading plots represent phenolic acids: A, 4-hydroxybenzoic acid; B, caffeic acid; C, vanillic acid; D, 4-hydroxybenzaldehyde; E, syringic acid;
F, p-coumaric acid; g, vanillin; h, ferulic acid; I, sinapic acid.
G. Soycan, et al. Food Chemistry: X 3 (2019) 100047
8
Declaration of Competing Interest
The authors declare no conflicts of interest.
Acknowledgements
The authors acknowledge support from the Biotechnology and
Biological Sciences Research Council of the UK (Grant BB/M002802/1
Development and application of phenolic-rich oats for the maintenance
of cardiovascular health). Rothamsted Research receives grant-aided
support from the Biotechnology and Biological Sciences Research
Council (BBSRC) of the UK and the work reported here forms part of the
Designing Future Wheat Institute Strategic Programme [BB/P016855/
1].
Appendix A. Supplementary data
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.fochx.2019.100047.
References
Bao, L., Cai, X., Xu, M., & Li, Y. (2014). Effect of oat intake on glycaemic control and
insulin sensitivity: A meta-analysis of randomised controlled trials. British Journal of
Nutrition, 112, 457–466.
Bratt, K., Sunnerheim, K., Bryngelsson, S., Fagerlund, A., Engman, L., Andersson, R. E.,
et al. (2003). Avenanthramides in oats (Avena sativa L.) and structure–antioxidant
activity relationships. Journal of Agricultural and Food Chemistry, 51, 594–600.
Bryngelsson, S., Dinberg, L. H., & Kamal-Eldin, A. (2002). Effects of commercial pro-
cessing on levels of antioxidants in oats (Avena sativa L.). Journal of Agricultural and
Food Chemistry, 50, 1890–1896.
Chen, C., Wang, L., Wang, R., Luo, X., Li, Y., Li, J., et al. (2018). Phenolic contents,
cellular antioxidant activity and antiproliferative capacity of different varieties of
oats. Food Chemistry, 239, 260–267.
Chen, C. Y., Milbury, P. E., Collins, F. W., & Blumberg, J. B. (2007). Avenanthramides are
bioavailable and have antioxidant activity in humans after acute consumption of an
enriched mixture from oats. Journal of Nutrition, 137, 1375–1382.
Collins, F. W. (1986). Oat phenolics: Structure, occurrence and function. In F. H. Webster
(Ed.). Oats: Chemistry and technology (pp. 227–295). St. Paul, MN: American
Association of Cereal Chemists.
Collins, F. W. (1989). Oat phenolics: Avenanthramides, novel substituted N-cinnamoy-
lanthranilate alkaloids from oat groats and hulls. Journal of Agricultural and Food
Chemistry, 37, 60–66.
Dimberg, L. H., Gissen, C., & Nilsson, J. (2005). Phenolic compounds in oat grains (Avena
Fig. 4. Principal component analysis of the contents of free+ conjugated phenolic acids and avenanthramides in different oat products. A, C and E are score plots
and B, D and F the corresponding loading plots. Letters on loading plots represent phenolic acids: A, 4-hydroxybenzoic acid; B, caffeic acid; C, vanillic acid; D, 4-
hydroxybenzaldehyde; E, syringic acid; F, p-coumaric acid; g, Vanillin; h, Ferulic acid; I, sinapic acid; J, avenanthramide C; K, avenanthramide A; L, avenanthramide
B.
G. Soycan, et al. Food Chemistry: X 3 (2019) 100047
9
sativa L.) grown in conventional and organic systems. Ambio, 34, 331–337.
Dinberg, L., Sunnerheim, K., Sundberg, B., & Walsh, K. (2001). Stability of oat avenan-
thramides. Cereal Chemistry, 78, 278–281.
Efsa Panel on Dietetic Products & Allergies (2011). Scientific Opinion on the sub-
stantiation of health claims related to beta-glucans from oats and barley and main-
tenance of normal blood LDL-cholesterol concentrations (ID 1236, 1299), increase in
satiety leading to a reduction in energy intake (ID 851, 852), reduction of post-
prandial glycaemic responses (ID 821, 824), and “digestive function” (ID 850) pur-
suant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal, 9, 2207.
Ho, H. V., Sievenpiper, J. L., Zurbau, A., Blanco Mejia, S., Jovanovski, E., Au-Yeung, F.,
et al. (2016). The effect of oat beta-glucan on LDL-cholesterol, non-HDL-cholesterol
and apoB for CVD risk reduction: A systematic review and meta-analysis of rando-
mised-controlled trials. British Journal of Nutrition, 116, 1369–1382.
Kováčová, M., & Malinová, E. (2007). Ferulic and coumaric acids, total phenolic com-
pounds and their correlation in selected oat genotypes Czech. Journal of Food Science,
25, 325–332.
Kumar, N., & Pruthi, V. (2014). Potential applications of ferulic acid from natural sources.
Biotechnology Reports, 4, 86–93.
Li, X.-P., Li, M.-Y., Ling, A. J., Hu, X.-Z., Ma, Z., Liu, L., et al. (2017). Effects of genotype
and environment on avenanthramides and antioxidant activity of oats grown in
northwestern China. Journal of Cereal Science, 73, 130–137.
Li, L., Shewry, P. R., & Ward, J. L. (2008). Phenolic acids in wheat varieties in the
HEALTHGRAIN diversity screen. Journal of Agricultural and Food Chemistry, 56,
9777–9784.
Liu, L., Zubik, L., Collins, F. W., Marko, M., & Meydani, M. (2004). The antiatherogenic
potential of oat phenolic compounds. Atherosclerosis, 175, 39–49.
Mattila, P., Pihlava, J. M., & Hellstrom, J. (2005). Contents of phenolic acids, alkyl- and
alkenylresorcinols, and avenanthramides in commercial grain products. Journal of
Agricultural and Food Chemistry, 53, 8290–8295.
Menon, R., Gonzalez, T., Ferruzzi, M., Jackson, E., Winderl, D., & Watson, J. (2016). Oats-
from farm to fork. Advances in Food and Nutrition Research, 77, 1–55.
Mills, C. E., Flury, A., Marmet, C., Poquet, L., Rimoldi, S. F., Sartori, C., et al. (2017).
Mediation of coffee-induced improvements in human vascular function by chloro-
genic acids and its metabolites: Two randomized, controlled, crossover intervention
trials. Clinical Nutrition, 36, 1520–1529.
Multari, S., Pihlava, J. M., Ollennu-Chuasam, P., Hietaniemi, V., Yang, B., & Suomela, J.
P. (2018). Identification and quantification of avenanthramides and free and bound
phenolic acids in eight cultivars of husked oat (Avena sativa L) from Finland. Journal
of Agricultural and Food Chemistry, 66, 2900–2908.
Nie, L., Wise, M. L., Peterson, D. M., & Meydani, M. (2006). Avenanthramide, a poly-
phenol from oats, inhibits vascular smooth muscle cell proliferation and enhances
nitric oxide production. Atherosclerosis, 186, 260–266.
Peterson, D. M. (2001). Oat antioxidants. Journal of Cereal Science, 33, 115–129.
Pridal, A. A., Bottger, W., & Ross, A. B. (2018). Analysis of avenanthramides in oat
products and estimation of avenanthramide intake in humans. Food Chemistry, 253,
93–100.
Reynolds, A., Mann, J., Cummings, J., Winter, N., Mete, E., & Te Morenga, L. (2019).
Carbohydrate quality and human health: A series of systematic reviews and meta-
analyses. The Lancet, 393, 434–445.
Rodriguez-Mateos, A., Feliciano, R. P., Boeres, A., Weber, T., Dos Santos, C. N., Ventura,
M. R., et al. (2016). Cranberry (poly)phenol metabolites correlate with improvements
in vascular function: A double-blind, randomized, controlled, dose-response, cross-
over study. Molecular Nutrition and Food Research, 60, 2130–2140.
Rodriguez-Mateos, A., Rendeiro, C., Bergillos-Meca, T., Tabatabaee, S., George, T. W.,
Heiss, C., et al. (2013). Intake and time dependence of blueberry flavonoid–induced
improvements in vascular function: A randomized, controlled, double-blind, cross-
over intervention study with mechanistic insights into biological activity. The
American Journal of Clinical Nutrition, 98, 1179–1191.
Sawicki, C. M., McKay, D. L., McKeown, N. M., Dallal, G., Chen, C., & Blumberg, J. B.
(2016). Phytochemical pharmacokinetics and bioactivity of oat and barley flour: a
randomized crossover trial. Nutrients, 8(12) pii: E813.
Schär, M. Y., Corona, G., Soycan, G., Dine, C., Kristek, A., Alsharif, S. N. S., et al. (2018).
Excretion of avenanthramides, phenolic acids and their major metabolites following
intake of oat bran. Molecular Nutrition and Food Research, 62, 1700499.
Schar, M. Y., Curtis, P. J., Hazim, S., Ostertag, L. M., Kay, C. D., Potter, J. F., et al. (2015).
Orange juice-derived flavanone and phenolic metabolites do not acutely affect car-
diovascular risk biomarkers: A randomized, placebo-controlled, crossover trial in
men at moderate risk of cardiovascular disease. American Journal of Clinical Nutrition,
101, 931–938.
Shahidi, F., & Yeo, J. (2018). Bioactivities of phenolics by focusing on suppression of
chronic diseases: A review. International Journal of Molecular Science, 19, 1573.
Shewry, P. R., Piironen, V., Lampi, A.-M., Edelmann, M., Kariluoto, S., Nurmi, T., et al.
(2010). The HEALTHGRAIN wheat diversity screen: Effects of genotype and en-
vironment on phytochemicals and dietary fiber components. Journal of Agricultural
and Food Chemistry, 58, 9291–9298.
Shewry, P. R., Piironen, V., Lampi, A.-M., Nyström, L., Li, L., Rakszegi, M., et al. (2008).
Phytochemical and fiber components in oat varieties in the HEALTHGRAIN diversity
screen. Journal of Agricultural and Food Chemistry, 56, 9777–9784.
Singh, R., De, S., & Belkheir, A. (2013). Avena sativa (Oat), a potential neutraceutical and
therapeutic agent: An overview. Critical Reviews in Food Science and Nutrition, 53,
126–144.
Vazour, D., Houseman, E. J., George, T., Corona, G., Garnotel, R., Jackson, K. G., et al.
(2010). Moderate champagne consumption promotes an acute improvement in acute
endothelial vascular function in healthy human volunteers. British Journal of
Nutrition, 103, 1168–1178.
Xie, Z., Mui, T., Sintara, M., Ou, B., Johnson, J., Chu, Y., et al. (2017). Rapid quantitation
of avenanthramides in oat-containing products by high-performance liquid chroma-
tography coupled with triple quadrupole mass spectrometry (HPLC-TQMS). Food
Chemistry, 224, 280–288.
Zamora-Ros, R., Knaze, V., Rothwell, J. A., Hémon, B., Moskal, A., Overvad, K., et al.
(2016). Dietary polyphenol intake in Europe: The European Prospective Investigation
into Cancer and Nutrition (EPIC) study. European Journal of Nutrition, 55(4),
1359–1375.
Zeng, Z., Liu, C., Luo, S., Chen, J., & Gong, E. (2016). The profile and bioaccessibility of
phenolic compounds in cereals influenced by improved extrusion cooking treatment.
PLoS One, 11, e0161086.
G. Soycan, et al. Food Chemistry: X 3 (2019) 100047
10
